NYSE:HIMSHealthcare
How Should Investors View Hims & Hers After Its 23% Price Drop This Quarter?
If you are debating what to do with your Hims & Hers Health stock right now, you are far from alone. The company has been on quite a ride lately. Over the past year, shares have skyrocketed by more than 160%, and the year-to-date return alone sits at an eye-popping 77%. But if you zoom out a bit, you will notice moments of real volatility too, with a roughly 23% dip over the last 30 days and a nearly 19% drop over the last quarter. These swings might make you wonder if the growth story is...